Five melanoma cell line pairs (A375, Mel1617, SKMel19, SKMel28, 451LU), consisting of a sensitive (S) and a secondary resistant (R) counterpart respectively, were used to assess the activation status of the p90 ribosomal S6 kinase and its relevance in BRAF inhibitor resistance. This evidence concerns the gene BRAF and melanoma.